US › Healthcare

Radiopharm Theranostics Limited American Depositary Shares (RADX)

US · Healthcare · Biotechnology

$1.73+3.59%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$1.4M

Net profit

$-28.6M

EPS

$0.00

EPS estimate

$0.00

Net margin

-2,038.8%

Key statistics

Market cap

$28.6M

Forward P/E

0.0

P/B

1.66

Book value

$1.51

EPS (TTM)

$-3.88

52-week high

$10.63

52-week low

$1.98

50-day MA

$3.13

200-day MA

$4.34

Beta

0.75

Analyst view

with an average price target of $17.49.

Shareholding

Institutions

0.80%

Largest institutional holders

Fund	Stake
SILVERARC CAPITAL MANAGEMENT, LLC	1.59%
HSBC Holdings PLC	0.52%
VGI Partners Ltd	0.34%
PNC Financial Services Group Inc	0.14%
UBS Group AG	0.03%
Integrated Wealth Concepts LLC	0.01%
Rhumbline Advisers	0.00%
Stonepine Capital Management Llc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Radiopharm Theranostics Limited American Depositary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.